The Precision Oncology: Genomics Guided Care Webinar Series recordings and slides are available to all ESMO account holders.
Precision Oncology: Genomics Guided Care – Update of the Recommendations for the Use of Next-Generation Sequencing (NGS) for Patients with Metastatic Cancer
Chair's welcome
It is with great pleasure that I invite you to participate in this webinar dedicated to the updated ESMO recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancer. This webinar is a part of four complimentary ESMO webinars in a series focusing on genomics guided care.
I am delighted to announce the presentations by distinguished experts who will join me in this webinar. We will begin with providing a general context and elaborating recommendations for NGS by the experts involved in ESMO Precision Medicine Working Group activities. This will follow with a discussion around recommendations in specific cancer types.
Overall, the programme is designed to enhance patient’s access to molecular tumour profiling by providing an overview of the contextualised scientific data, offering an expert opinion exchange, and providing key considerations for evidence-based approaches for NGS implementation in cancer care.
It is designed for those oncologists keen to keep abreast with rapidly evolving molecular approaches and their applications into clinical practice.
I encourage you to register and join us all in this new ESMO activity.
Prof. Fabrice André
Gustave Roussy, Villejuif, France
Speakers
Programme
Time |
Title |
Speaker |
|---|---|---|
5 min |
Welcome and Introduction |
Fabrice André |
15 min |
General recommendations for NGS |
Fernanda Mosele |
20 min |
Discussion around specific cancers |
Benedikt Westphalen |
15 min |
LIVE Q&A |
All |
5 min |
Conclusions |
Fabrice André |
Live viewers of the webinar will be awarded a certificate of attendance and 1 ESMO-MORA category 1 point
Learning objectives:
- Discuss the updated and new recommendations for the use of next-generation sequencing (NGS) based on the quick evolvement of precision cancer medicine.
- Enhance the use of NGS as a high throughput technology in daily practice.
- Enhance patient's access to NGS and molecular tumour profiling.
Supported by
Meeting resources
The Precision Oncology: Genomics Guided Care Webinar Series recordings and slides are available to all ESMO account holders.